Ms. Natalie Brown began her career at EKG Labs as an intern under the direct supervision of Chief Science Officer, Allen Kesselring. Upon graduating from Missouri Baptist University with a BS in Chemistry, Natalie became one of the company’s full-time analyst. She executed procedures according to cGXP regulations, worked with various DEA controlled substances, and maintained, operated, and qualified analytical instruments such as HPLC, ICP-MS and GCMS.
Natalie began to make a name for herself throughout the company and industry by representing EKG at numerous industry events while also managing her own internal team. In 2019, Natalie proposed expanding into new areas, and she worked together with EKG’s founding members to add a medical marijuana division to company. She has been actively involved in executing strategies as directed from the management team, developing and promoting company policies, planning and monitoring the day-to-day operations of the company while also serving as the primary liaison for the company.